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Abstract
Introduction Stroke volume variation (SVV) has repeatedly
been shown to be a reliable predictor of fluid responsiveness.
Various devices allow automated clinical assessment of SVV.
The aim of the present study was to compare prediction of fluid
responsiveness using SVV, as determined by the FloTrac™/
Vigileo™ system and the PiCCOplus™ system.
Methods In patients who had undergone elective cardiac
surgery, SVVFloTrac was determined via radial FloTrac sensor,
and SVVPiCCO and pulse pressure variation were assessed via a
femoral PiCCO catheter. Stroke volume was assessed by
transpulmonary thermodilution. All variables were recorded
before and after a volume shift induced by a change in body
positioning (from 30° head-up position to 30° head-down
position). Pearson correlation, t-test, and Bland-Altman analysis
were performed. Area under the curve was determined by
plotting receiver operating characteristic curves for changes in
stroke volume in excess of 25%. P  < 0.05 was considered
statistically significant.
Results Body positioning resulted in a significant increase in
stroke volume; SVVFloTrac and SVVPiCCO decreased significantly.
Correlations of SVVFloTrac and SVVPiCCO with change in stroke
volume were similar. There was no significant difference
between the areas under the curve for SVVFloTrac and SVVPiCCO;
the optimal threshold values given by the receiver operating
characteristic curves were 9.6% for SVVFloTrac (sensitivity 91%
and specificity 83%) and 12.1% for SVVPiCCO (sensitivity 87%
and specificity 76%). There was a clinically acceptable
agreement and strong correlation between SVVFloTrac  and
SVVPiCCO.
Conclusion SVVs assessed using the FloTrac™/Vigileo™ and
the PiCCOplus™ systems exhibited similar performances in
terms of predicting fluid responsiveness. In comparison with
SVVPiCCO, SVVFloTrac has a lower threshold value.
Introduction
Fluid administration in critically ill patients is typically per-
formed to increase cardiac preload, followed by a raise in car-
diac output. However, studies conducted during the past few
years have shown that about 50% of critically ill patients do
not exhibit the desired effect (they are not fluid responsive) [1].
Thus, we require an accurate and reliable technique to guide
fluid management. Pressure preload variables (central venous
pressure and pulmonary capillary wedge pressure), which
continue to be used, often fail to provide reliable information
regarding cardiac preload [2] and are incapable of predicting
cardiac response to fluid therapy [3]. On the other hand, the
volumetric preload variables that are assessed by transpulmo-
nary thermodilution may better reflect left ventricular preload
[4], but they do not allow assessment of fluid responsiveness
[3,5].
As an alternative to these static variables, a dynamic approach
may be used in the form of preload monitoring to guide fluid
therapy. With passive leg rising in spontaneously breathing
AUC = area under the receiver operating characteristic curve; CVP = central venous pressure; GEDV = global end-diastolic volume; PPV = pulse 
pressure variation; ROC = receiver operating characteristic; SV = stroke volume; SVV = stroke volume variation; SVVFloTrac = SVV assessed using 
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patients, the heart's reaction (increased venous return) can be
assessed without any fluid administration [6], and in mechani-
cally ventilated patients the interaction between heart and lung
can be used to predict fluid responsiveness [7].
Different, less invasive haemodynamic monitoring systems
based on arterial pulse contour analysis allow stroke volume
variation (SVV) to be tracked continuously. SVV assessed
using the PiCCOplus™ system (Pulsion Medical Systems,
Munich, Germany; SVVPiCCO) has repeatedly been shown to
predict fluid responsiveness well in various clinical set-
tings[3,8-11], whereas only sparse data are available for SVV
determined using the recently introduced FloTrac™/Vigileo™
system (Edwards Lifesciences, Irvine, CA, USA; SVVFloTrac). In
a study conducted by de Waal and coworkers [12], SVVFloTrac
failed to predict fluid responsiveness. This finding may be
attributable to the initial version of the device's software,
adapting vascular compliance every 10 minutes. Limited accu-
racy in assessment of cardiac output (and thus of stroke vol-
ume) could be achieved using this early software version [13].
Modification to the software (reduction in the time window for
vascular adjustment to 1 minute) resulted in improved accu-
racy in measuring cardiac output [14].
The aim of the present study was to compare SVVFloTrac with
SVVPiCCO during a volume shift manoeuvre (by changing body
positioning) in patients who had undergone elective off-pump
coronary artery bypass grafting.
Materials and methods
Patients and setting
Patients undergoing elective coronary artery bypass grafting
gave written, informed consent to participate in the study,
which was approved by the local ethics committee. Exclusion
criteria were reduced left and right ventricular function (ejec-
tion fraction < 40%), preoperative dysrhythmia, intracardiac
shunt, pulmonary arterial hypertension, severe arterial occlu-
sion disease and body weight under 40 kg. We calculated that
a sample size of 40 patients was necessary, based on an
expected standard deviation of 5% in SVV values and an
expected difference between SVV assessed using the differ-
ent systems in the same range (α = 0.05 and power = 0.9).
Routine perioperative management
Perioperative management was in accordance with institu-
tional standards. Routine monitoring (Philips IntelliVue™ Moni-
toring; Philips Medical Systems, Andover, MA, USA) during
the perioperative period included pulse oxymetry, five-lead
electrocardiography, and invasive blood pressure measure-
ment (via a peripheral radial arterial) and central venous pres-
sure (assessed using standard transducers; Truewave™ PX,
Edwards Lifesciences). During the time when the study was
performed, continuous cardiac output monitoring with the PiC-
COplus™ system was routine in the selected patient group. A
4F thermistor-tipped arterial catheter (Pulsiocath™ thermodilu-
tion catheter) was inserted into the left femoral artery, and its
tip was advanced to the abdominal aorta and connected to a
stand-alone PiCCOplus™ monitor (software version 6.0; Pul-
sion Medical Systems, Munich, Germany). Continuous cardiac
output measurement was initiated after initial calibration of the
system by injection three times of 20 ml ice-cold normal saline
into the central venous catheter (transpulmonary
thermodilution).
Study protocol
Measurements were started during the postoperative period
after transfer of patients to the intensive care unit. The patients
remained sedated during the study period using propofol (1 to
2 mg/kg per hour) and remifentanil (2 to 5 μg/kg per hour);
rocuronium (0.2 to 0.5 mg/kg per hour) was given for neu-
romuscular blockade. The patients were mechanically venti-
lated using a volume-controlled mode (tidal volume 8 to 10 ml/
kg, respiratory frequency 12 breaths/minute, positive end-
expiratory pressure 5 cmH2O, peak inspiratory pressure 23 ±
3 cmH2O) in order to achieve normoventilation (partial carbon
dioxide tension 4 to 4.5 kPa). Weaning from the ventilator was
begun after completion of the study protocol. Mean arterial
pressure was maintained between 65 and 75 mmHg by
adjusting the patient's noradrenaline (norepinephrine) dose (0
to 10 μg/minute). A regular heart rhythm was maintained in all
patients by fixed external pacing at a heart rate between 80 to
90 beats/minute.
The femoral PiCCO™ catheter was connected to a standalone
PiCCOplus™ monitor (computer version 6.0.1; Pulsion Medi-
cal Systems) and recalibrated in accordance with the manu-
facturer's instruction. A FloTrac™ sensor kit was connected to
the radial arterial line and coupled to the Vigileo™ monitor
(software version 1.07; Edwards Lifesciences). Individual
patient data (age [years], sex, body weight [kg] and height
[cm]) were entered. After checking the fidelity of the arterial
line waveform, the system was zeroed at mid-axillary level to
ambient pressure and measurements were initiated. Measure-
ments were performed 15 minutes before and after a volume
shift induced by a change to body positioning (from 30° head-
up position to 30° head-down position). At both measurement
time points the following continuous haemodynamic variables
were recorded: mean arterial pressure, heart rate and central
venous pressure (CVP). Also recorded were stroke volume
(SV) and SVVFloTrac determined using the FloTrac™/Vigileo™
system, and SV, SVVPiCCO and pulse pressure variation (PPV)
determined using the PiCCOplus™ system. Immediately after,
triplicate transpulmonary thermodilution measurements of 20
ml normal iced saline solution were performed in order to
determine cardiac output, SV and global end-diastolic volume
(GEDV).
SVV determination
SVV is calculated from percentage changes in SV during the
ventilatory cycle. SV is assessed by the FloTrac™/Vigileo™ andAvailable online http://ccforum.com/content/12/3/R82
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the PiCCOplus™ system using different proprietary algo-
rithms, which have been described in detail elsewhere [14-
16]. Briefly, calculation of SV by the FloTrac™/Vigileo™ system
is based on the contribution of pulse pressure to SV being pro-
portional to the standard deviation of arterial pulse pressure. In
order to determine SV, the influences of vascular resistance
and compliance on SV are considered using manually entered
patient data and pulse wave analysis. In contrast, the PiCCO-
plus™ method relies on work conducted by Wesseling and
coworkers [17], calculating cardiac output by measuring the
area under the systolic part of the arterial pressure wave form
and dividing this area by the aortic impedance. For adequate
determination of SV and adjustment of individual aortic com-
pliance, however, calibration by transpulmonary thermodilution
is required.
SVV is assessed by both systems using the following equa-
tion: SVV (%) = (SVmax - SVmin)/SVmean. SVmax, SVmin and
SVmean are determined by the FloTrac™/Vigileo™ system dur-
ing a time window of 20 seconds. The system can detect and
eliminate premature ventricular contractions or other arrhyth-
mias for assessment of SVV. The PiCCOplus™ system meas-
ures SVmax and SVmin as mean values of the four extreme
values of SV during a measurement period of 30 seconds and
SVmean is recorded as the average value during this time
period. In addition, using the PiCCOplus system, PPV can be
determined during the same time interval [3].
Data analysis
All haemodynamic variables were recorded as mean values of
three repeated measurements. Statistical analysis was per-
formed using Statview® 5.01 Software (SAS Institute Inc.
Cary, NC, USA) and SPSS® 10.0 (SPSS® Inc., Chicago, IL,
USA). Student's t-test was used for comparison of haemody-
namic data before and after change in body position. Pear-
son's correlation between stroke volume changes and
changes in the various haemodynamic variables was estab-
lished. Prediction of fluid responsiveness based on SVVFloTrac,
SVVPiCCO, PPV and static preload variables (CVP and GEDV)
was tested by calculating the AUC (area under the receiver
operating characteristic [ROC] curve) for a SV increase
greater than 25%. Threshold values for SVVFloTrac, SVVPiCCO
and PPV were determined by considering values that yielded
the greatest sensitivity and specificity. Based on these thresh-
old values, the positive and negative predictive values for all
dynamic variables were calculated. Additionally, regression
analysis was performed for preload variables and SV changes.
Comparison of SVVFloTrac with SVVPiCCO was done by Bland-
Altman analysis and Pearson's correlation. ROC curves were
compared in accordance with the method established by
Hanley and coworkers [18]. Linear correlations were com-
pared using Fisher z-transformation and Hotelling-Williams
test. Identification of patients with a SV increase greater than
25% using SVVFloTrac and SVVPiCCO was compared by χ2 test.
P < 0.05 was considered to be statistically significant. Unless
otherwise stated, data are presented as mean ± standard
deviation.
Results
40 patients (american society of anesthesiologists risk classi-
fication III, female/male ratio 1/4, age 66.5 ± 9.2 years, left
ventricular ejection fraction 56.1 ± 10.0%) were enrolled in
this study. During the study period, no significant changes in
ventilatory tidal volumes or peak inspiratory pressure were
identified.
Change in body position from 30° head-up to 30° head-down
resulted in significantly increased SV, GEDV and CVP,
whereas SVVFloTrac, SVVPiCCO  and PPV significantly
decreased (Table 1 and Figure 1). The mean increase in SV
was 24 ± 14%. Twenty-three patients (58%) had an increase
in SV of greater than 25% (mean change 34 ± 9%). A SV
increase of under 10% was observed in eight patients (20%;
mean change = 5 ± 3%).
For patients with an increase in SV of greater than 25%, base-
line SVVFloTrac and SVVPiCCO were 16 ± 4% and 19 ± 5%,
respectively. In patients with an increase in SV of under 10%,
baseline SVVFloTrac and SVVPiCCO were 9 ± 2% and 11 ± 3%,
respectively. Results of ROC curve and linear regression anal-
yses for the prediction of SV changes induced by altered body
positioning are summarized in Figure 2 and Table 2. There was
no significant difference between AUCs with respect to iden-
tifying a SV increase of more than 25% for SVVFloTrac and
SVVPiCCO (Table 3). Optimal threshold values given by the
ROC curves were 9.6% for SVVFloTrac (sensitivity 91% and
specificity 83%) and 12.1% for SVVPiCCO (sensitivity 87% and
specificity 76%). Based on these threshold values, positive
and negative predictive values were 80% and 92% for SVV-
Table 1
Haemodynamic data
Parameter 30° head-up 30° head-down P
HR (beats/minute) 87 ± 9 87 ± 8 0.297
MAP (mmHg) 70 ± 9 80 ± 10 <0.001
SVR (dyne·second/cm5) 955 ± 178 898 ± 199 0.032
CO (l/minute) 5.0 ± 0.8 6.3 ± 1.2 <0.001
SV (ml) 60 ± 12 76 ± 14 <0.001
SVVFloTrac (%) 14 ± 4 8 ± 3 <0.001
SVVPiCCO (%) 16 ± 5 9 ± 4 <0.001
PPV (%) 15 ± 6 8 ± 4 <0.001
CVP (mmHg) 7 ± 3 11 ± 3 <0.001
GEDV (ml) 1214 ± 354 1356 ± 392 <0.001
CO, cardiac output; CVP, central venous pressure; GEDV, global 
end-diastolic volume; HR, heart rate; MAP, mean arterial pressure; 
PPV, pulse pressure variation; SV, stroke volume; SVR, systemic 
vascular resistance; SVV, stroke volume variation.Critical Care    Vol 12 No 3    Hofer et al.
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FloTrac, respectively; corresponding values for SVVPiCCO were
77% and 90%. There was no significant difference between
identification of patients with a SV increase of more than 25%
using SVVFloTrac  and SVVPiCCO  (P  = 0.523). Correlations
between SVVFloTrac and SVVPiCCO and changes of SV (ΔSV)
were similar (Tables 2 and 4, and Figure 3).
The AUCs for PPV, GEDV and CVP were significantly lower
than the AUCs for SVVFloTrac and SVVPiCCO (Table 3). The opti-
mal threshold value was 15.4% for PPV, yielding a sensitivity
of 60% and a specificity of 62%, and negative and positive
predictive values being 68% and 60%, respectively. Moreo-
ver, the correlation between PPV with ΔSV was significant,
whereas no significant correlations of GEDV and CVP with
ΔSV could be established (Tables 2 and 4).
Bland-Altman analysis (SVVFloTrac - SVVPiCCO) revealed a mean
bias ± 2 standard deviations (limits of agreement) of -2.5 ±
6.1% for head-up measurements and -1.5 ± 3.6% for head-
down measurements (Figure 4). Correlation coefficients for
SVVFloTrac versus SVVPiCCO (r2) were 0.612 and 0.757 for
head-up and head-down measurements, respectively.
Discussion
SVVs as assessed using the modified FloTrac™/Vigileo™ and
the PiCCOplus™ systems were comparable predictors of SV
changes related to a fluid shift manoeuvre in patients who had
undergone off-pump coronary artery bypass grafting. There
was clinically acceptable agreement and a strong correlation
between SVV assessed using the two devices. However, in
comparison with SVVPiCCO, it must be noted that the SVVFloTrac
device has a lower threshold value.
Differences between the devices in terms of absolute values,
and thus their threshold values, may primarily be explained by
different signal detection sites and specific differences in the
measurement techniques, despite the fact that both systems
use a similar SVV algorithm. Both the FloTrac/Vigileo™ and the
PiCCOplus™ system are based on analysis of pulse pressure
which is the result of the interaction between SV and the sys-
temic vascular system. Therefore, vascular resistance and
compliance at the site of signal detection must be considered
in order to determine SV and SVV reliably. The FloTrac/Vig-
ileo™ system assesses SV typically using signal detection via
a peripheral radial artery. It analyzes the impact of vascular
tone on pressure during a period of 20 seconds, and adjusts
for actual vascular tone at intervals of 1 minute based on wave
form analysis and patient characteristics. In contrast, with the
Figure 1
Individual responses of SV, SVVFloTrac and SVVPiCCO to 30° head-down positioning Individual responses of SV, SVVFloTrac and SVVPiCCO to 30° head-down positioning. SV, stroke volume; SVV, stroke volume variation.
Figure 2
Prediction of fluid responsiveness to SV changes > 25% induced by  30° head-down positioning Prediction of fluid responsiveness to SV changes > 25% induced by 
30° head-down positioning. CVP, central venous pressure; GEDV, glo-
bal end-diastolic volume; PPV, pulse pressure variation; SVV, stroke 
volume variation.Available online http://ccforum.com/content/12/3/R82
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PiCCOplus™ system aortic pressure wave forms are recorded
usually via a specific thermistor-tipped arterial catheter in the
femoral artery. SV is then calculated using an algorithm that
assesses the area under the systolic part of the pressure wave
form beat-to-beat after calibration by transpulmonary ther-
modilution [16].
Only limited data are available regarding SVV as assessed
using the FloTrac/Vigileo™ system. Recently, de Waal and
coworkers [12] demonstrated that SVVFloTrac was unable to
predict fluid responsiveness in cardiac surgery patients; their
findings contradict those of the present study. However, de
Waal and coworkers used the FloTrac/Vigileo™ system with
an early version of the software, which employed a time win-
dow for adjustment to vascular tone of 10 minutes. Based on
the limited accuracy of cardiac output assessment observed
with this early software version [13], the algorithm has been
modified and – a major change – the time window has been
reduced to 1 minute. These modifications resulted in improved
measurement of cardiac output [14], and in the present study,
in which we used a new software version, we demonstrated
that SVVFloTrac is useful for predicting fluid responsiveness.
Figure 3
Prediction of fluid responsiveness: Pearson correlations Prediction of fluid responsiveness: Pearson correlations. Shown are Pearson correlations between stroke volume variation (SVV) assessed using the 
FloTrac™/Vigileo™ and the PiCCOplus™ systems in head-up position and stroke volume (SV) changes induced by 30° head-down positioning. ΔSV, 
stroke volume change (%).
Table 2
Prediction of stroke volume responsiveness
Baseline haemodynamic indices ROC curves: predicting ΔSV > 25% Pearson's correlation: baseline haemodynamic indices versus ΔSV
AUC 95% CI Pa r2 P
SVVFloTrac 0.824 0.680 to 0.967 <0.001 0.426 <0.001
SVVPiCCO 0.858 0.745 to 0.971 <0.001 0.492 <0.001
PPV 0.718 0.578 to 0.898 0.011 0.334 <0.001
GEDV 0.509 0.323 to 0.695 0.632 0.061 0.580
CVP 0.299 0.134 to 0.465 0.924 0.010 0.730
aComparison with AUC = 0.5. AUC, area under the ROC curve; CI, confidence interval; CVP, central venous pressure; GEDV, global end-
diastolic volume; PPV, pulse pressure variation; r2, Pearson correlation coefficient; ROC, receiver operating characteristic; ΔSV, % change in 
stroke volume; SVV, stroke volume variation.Critical Care    Vol 12 No 3    Hofer et al.
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The SVVPiCCO findings in the present study are in agreement
with those of a variety of previous investigations. SVVPiCCO
could predict fluid responsiveness in patients with severe sep-
sis [8], in those undergoing neurosurgery [19] and in cardiac
surgery patients with preserved [3,9,10] as well as reduced
left ventricular function [9]. Interestingly, Wiesenack and cow-
orkers [20] identified no correlation between SVVPiCCO and SV
changes during a fluid trial using an older version of the
PiCCO algorithm. However, favourable results however were
later reported by the same study group [11] using a PiCCO
algorithm that has been modified to address better aortic com-
pliance in the individual patient.
Despite the clinical importance of SVV threshold values, little
information is available in the literature. A SVV threshold value
represents the 'trigger' value at which initiation of fluid replace-
ment therapy is expected to result in a positive cardiac
response. ROC analyses performed thus far have revealed
that SVVPiCCO at the threshold value of 9.5% results in a step-
wise SV index increase of 5% or more in studies involving
incremental volume administration [9,19]. In a previous study
[3] we observed that a SVVPiCCO threshold value of 12.5%
resulted in an increase in SV index of 25% or more after fluid
loading. In the present study, by inducing a fluid shift by alter-
ing body positioning, a comparable SVVPiCCO threshold value
(12.1%) for SV increase greater than 25% was identified,
whereas the SVV threshold value for the FloTrac/Vigileo™ sys-
tem was 9.6%.
Variations in SV are followed by concomitant changes in arte-
rial pressure, which can be assessed by measuring PPV. In
addition to SVV, the PiCCOplus  system allows automated
assessment of PPV. Reuter and coworkers [21] found a close
correlation between PPV and SVV. Moreover, in a previous
study [3], we demonstrated that both SVV and PPV were sim-
ilarly able to predict fluid responsiveness. However in the
present study the predictive performance of PPV was inferior
to those of SVVFlotrac and SVVPiCCO; it is likely that this finding
is mainly accounted for by the study design. In this study
preload changes were induced by changes in body position-
ing, whereas in the previous study [3] a fluid trial using hetas-
tarch solution was performed. Body positioning might have
influenced vascular tone, and PPV is known to be more sus-
ceptible to changes in vasomotor tone than SVV [22].
In contrast to SVV and PPV, conventional static preload
parameters assessed in this study failed to predict fluid
responsiveness, confirming the findings of previous work
related to this issue [3,23]. CVP, the standard pressure
preload variable, did not adequately reflect preload status
[2,4] and is therefore unsuitable for predicting ventricular
response to fluid loading. GEDV, a volumetric preload variable,
more adequately reflected changes in cardiac preload [4,24],
but this parameter also failed to predict the reaction of the
heart to fluid loading.
When interpreting of the data presented in this study, some
methodological aspects and limitations must be considered.
First, we induced a fluid shift by changing body positioning
and not by subjecting patients to a 'real' fluid challenge.
Changes in body positioning might have resulted in alterations
to systemic vascular resistance based on sympathetic activity
and not on changes in preload in isolation. Thus, a fluid shift
due to changed body positioning and a true episode of hypo-
volaemia followed by intravenous fluid administration are not
necessarily comparable. However, the sympathetic effect was
minimized by using adequate sedation and analgesia in all
patients during the study. Furthermore, the significant increase
in GEDV observed after changed body positioning indicates
an increase in preload. Moreover, body positioning is a typical
manoeuvre for assessing fluid responsiveness [1,6]. In addi-
tion, a similar approach has previously been used to determine
fluid responsiveness of SVVPiCCO [10], and we previously
observed a similar haemodynamic pattern and comparable
threshold value for SVVPiCCO in a true fluid challenge [3]. Sec-
ond, mechanical ventilation and a regular heart rhythm are pre-
requisites for reliable SVV assessment. In order to satisfy
these requirements, patients were fully sedated, neuromuscu-
lar blockade was used and fixed cardiac pacing was applied in
all patients. However, pacing resulted in a lack of heart rate
response to the fluid shift. Moreover, it may not be possible to
achieve these optimal conditions in clinical practice.
Table 3
P values for comparisons of ROC curves
SVVFloTrac SVVPiCCO PPV GEDV
SVVPiCCO 0.616
PPV 0.039 0.042
GEDV 0.015 0.009 0.119
CVP <0.001 <0.001 0.042 0.233
CVP, central venous pressure; GEDV, global end-diastolic volume; 
PPV, pulse pressure variation; ROC, receiver operating 
characteristic; SVV, stroke volume variation.
Table 4
Pearson correlation coefficients (r2)
SVVFloTrac SVVPiCCO PPV GEDV
SVVPiCCO 0.749
PPV 0.295 0.171
GEDV 0.016 0.008 0.049
CVP 0.002 0.001 0.026 0.368
CVP, central venous pressure; GEDV, global end-diastolic volume; 
PPV, pulse pressure variation; ROC, receiver operating 
characteristic; SVV, stroke volume variation.Available online http://ccforum.com/content/12/3/R82
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Thus, our findings may not be directly applicable to other situ-
ations or to patients other than the population studied
(patients with preserved left ventricular function after elective
cardiac surgery). Therefore, further evaluation of SVVFloTrac
using intravenous fluid administration under different condi-
tions and populations of critically ill patients is needed.
Conclusion
In conclusion, SVV assessed using the FloTrac™/Vigileo™ and
the PiCCOplus™ system exhibited comparable performance
in terms of predicting fluid responsiveness. However, in com-
parison with SVVPiCCO, SVVFloTrac has a lower threshold value.
Competing interests
This study was supported in part by a research grant from
Edwards Lifesciences (Irvine, CA, USA). In the past, the Insti-
tute of Anaesthesiology and Intensive Care Medicine, Triemli
City Hospital have held research grants from Pulsion Medical
Systems (Munich, Germany) and Edwards Lifesciences. CKH
has received lecture fees from both Pulsion Medical Systems
and Edwards Lifesciences in the past.
Authors' contributions
CKH was responsible for study design and protocol, patient
recruitment, measurements, data collection, statistical analysis
and manuscript writing. AS was responsible for patient recruit-
ment, measurements, data collection and manuscript writing.
LW was responsible for patient recruitment, data collection
and technical support. AZ was responsible for study design
and protocol.
Acknowledgements
This study was supported in part by a research grant from Edwards 
Lifesciences (Irvine, CA, USA).
References
1. Monnet X, Teboul JL: Volume responsiveness.  Curr Opin Crit
Care 2007, 13:549-53.
2. Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S, Neu-
mann A, Ali A, Cheang M, Kavinsky C, Parrillo JE: Pulmonary
artery occlusion pressure and central venous pressure fail to
predict ventricular filling volume, cardiac performance, or the
response to volume infusion in normal subjects.  Crit Care Med
2004, 32:691-699.
Figure 4
Bland-Altman analysis Bland-Altman analysis. Presented is a Bland-Altman analysis comparing stroke volume variation (SVV) assessed using the FloTrac™/Vigileo™ and 
the PiCCOplus™ system in 30° head-up and 30° head-down positions. 30° head-up: mean bias ± 2 standard deviations (SD; limits of agreement) = 
-2.5 ± 6.1%; 30° head-down: mean bias ± 2SD = -1.5 ± 3.6%.
Key messages
￿ Fluid  responsiveness  can  reliably be assessed using 
SVV determined using the modified FloTrac™/Vigileo™ 
system.
￿  SVV assessed using the modified FloTrac™/Vigileo™ 
and the PiCCOplus™ systems exhibited similar 
performance.
￿  The threshold value was lower for SVVFloTrac (9.6%) 
than for SVVPiCCO (12.1%).
￿  Compared with SVV, PPV was inferior in terms of pre-
dicting fluid responsiveness; static preload variables 
assessed in the study failed to provide valuable informa-
tion on fluid responsiveness.Critical Care    Vol 12 No 3    Hofer et al.
Page 8 of 8
(page number not for citation purposes)
3. Hofer CK, Muller SM, Furrer L, Klaghofer R, Genoni M, Zollinger A:
Stroke volume and pulse pressure variation for prediction of
fluid responsiveness in patients undergoing off-pump coro-
nary artery bypass grafting.  Chest 2005, 128:848-854.
4. Hofer CK, Furrer L, Matter-Ensner S, Maloigne M, Klaghofer R,
Genoni M, Zollinger A: Volumetric preload measurement by
thermodilution: a comparison with transoesophageal
echocardiography.  Br J Anaesth 2005, 94:748-755.
5. Reuter DA, Felbinger TW, Schmidt C, Kilger E, Goedje O, Lamm
P, Goetz AE: Stroke volume variations for assessment of car-
diac responsiveness to volume loading in mechanically venti-
lated patients after cardiac surgery.  Intensive Care Med 2002,
28:392-398.
6. Monnet X, Teboul JL: Passive leg raising.  Intensive Care Med
2008, 34:659-663.
7. Michard F, Teboul JL: Using heart-lung interactions to assess
fluid responsiveness during mechanical ventilation.  Crit Care
2000, 4:282-289.
8. Marx G, Cope T, McCrossan L, Swaraj S, Cowan C, Mostafa SM,
Wenstone R, Leuwer M: Assessing fluid responsiveness by
stroke volume variation in mechanically ventilated patients
with severe sepsis.  Eur J Anaesthesiol 2004, 21:132-138.
9. Reuter DA, Kirchner A, Felbinger TW, Weis FC, Kilger E, Lamm P,
Goetz AE: Usefulness of left ventricular stroke volume varia-
tion to assess fluid responsiveness in patients with reduced
cardiac function.  Crit Care Med 2003, 31:1399-1404.
10. Rex S, Brose S, Metzelder S, Huneke R, Schalte G, Autschbach R,
Rossaint R, Buhre W: Prediction of fluid responsiveness in
patients during cardiac surgery.  Br J Anaesth 2004,
93:782-788.
11. Wiesenack C, Fiegl C, Keyser A, Prasser C, Keyl C: Assessment
of fluid responsiveness in mechanically ventilated cardiac sur-
gical patients.  Eur J Anaesthesiol 2005, 22:658-665.
12. de Waal EE, Rex S, Kruitwagen CL, Kalkman CJ, Buhre WF:
Stroke volume variation obtained with FloTrac/Vigileo fails to
predict fluid responsiveness in coronary artery bypass graft
patients.  Br J Anaesth 2008, 100:725-726.
13. Mayer J, Boldt J, Schollhorn T, Rohm KD, Mengistu AM, Suttner S:
Semi-invasive monitoring of cardiac output by a new device
using arterial pressure waveform analysis: a comparison with
intermittent pulmonary artery thermodilution in patients
undergoing cardiac surgery.  Br J Anaesth 2007, 98:176-182.
14. Button D, Weibel L, Reuthebuch O, Genoni M, Zollinger A, Hofer
CK: Clinical evaluation of the FloTrac/Vigileo system and two
established continuous cardiac output monitoring devices in
patients undergoing cardiac surgery.  Br J Anaesth 2007,
99:329-336.
15. Godje O, Hoke K, Goetz AE, Felbinger TW, Reuter DA, Reichart
B, Friedl R, Hannekum A, Pfeiffer UJ: Reliability of a new algo-
rithm for continuous cardiac output determination by pulse-
contour analysis during hemodynamic instability.  Crit Care
Med 2002, 30:52-58.
16. Hofer CK, Ganter MT, Zollinger A: What technique should I use
to measure cardiac output?  Curr Opin Crit Care 2007,
13:308-317.
17. Wesseling KH, Purschke R, Smith NT, Wust HJ, de Wit B, Weber
HA: A computer module for the continuous monitoring of car-
diac output in the operating theatre and the ICU.  Acta Anaes-
thesiol Belg 1976, 27(suppl):327-341.
18. Hanley JA, McNeil BJ: A method of comparing the areas under
receiver operating characteristic curves derived from the
same cases.  Radiology 1983, 148:839-843.
19. Berkenstadt H, Margalit N, Hadani M, Friedman Z, Segal E, Villa Y,
Perel A: Stroke volume variation as a predictor of fluid respon-
siveness in patients undergoing brain surgery.  Anesth Analg
2001, 92:984-989.
20. Wiesenack C, Prasser C, Rodig G, Keyl C: Stroke volume varia-
tion as an indicator of fluid responsiveness using pulse con-
tour analysis in mechanically ventilated patients.  Anesth Analg
2003, 96:1254-1257.
21. Reuter DA, Goresch T, Goepfert MS, Wildhirt SM, Kilger E, Goetz
AE:  Effects of mid-line thoracotomy on the interaction
between mechanical ventilation and cardiac filling during car-
diac surgery.  Br J Anaesth 2004, 92:808-813.
22. Pinsky MR: Probing the limits of arterial pulse contour analysis
to predict preload responsiveness.  Anesth Analg 2003,
96:1245-1247.
23. Michard F, Teboul JL: Predicting fluid responsiveness in ICU
patients: a critical analysis of the evidence.  Chest 2002,
121:2000-2008.
24. Buhre W, Buhre K, Kazmaier S, Sonntag H, Weyland A: Assess-
ment of cardiac preload by indicator dilution and tran-
soesophageal echocardiography.  Eur J Anaesthesiol 2001,
18:662-667.